1. Rui-Juan Lv, Qun Wang, Tao Cui, Fei Zhu, Xiao-Qiu Shao. Status epilepticus-related etiology, incidence and mortality: A meta-analysis, Epilepsy Research, Volume 136, 2017, Pages 12-17, ISSN 0920-1211, Doi: 10.1016/j.eplepsyres.2017.07.006.
2. A definition and classification of status epilepticus – Report of the ILAE Task Force on Classification of Status Epilepticus;Trinka;Epilepsia,2015
3. Salzburg Consensus Criteria for Non-Convulsive Status Epilepticus–approach to clinical application;Leitinger;Epilepsy Behav,2015
4. Intramuscular versus intravenous therapy for prehospital status epilepticus;Silbergleit;N Engl J Med,2012
5. Chamberlain JM, Kapur J, Shinnar S, Elm J, Holsti M, Babcock L, Rogers A, Barsan W, Cloyd J, Lowenstein D, Bleck TP, Conwit R, Meinzer C, Cock H, Fountain NB, Underwood E, Connor JT, Silbergleit R; Neurological Emergencies Treatment Trials; Pediatric Emergency Care Applied Research Network investigators. Efficacy of levetiracetam, fosphenytoin, and valproate for established status epilepticus by age group (ESETT): a double-blind, responsive-adaptive, randomised controlled trial. Lancet. 2020 Apr 11;395(10231):1217-1224. doi: 10.1016/S0140-6736(20)30611-5. Epub 2020 Mar 20. Erratum in: Lancet. 2023 May 6;401(10387):1498. PMID: 32203691; PMCID: PMC7241415.